Skip to main content

Greenberg Traurig Advises Private Equity Fund Gilde Healthcare on Partnering with Surgical Instrument Manufacturer Chr. Diener

Greenberg Traurig has advised Gilde Healthcare, a European private equity fund specializing in healthcare investments, on the acquisition of a majority stake in Chr. Diener. The internationally active, family-run company manufactures customer-specific precision surgical instruments. The parties have agreed not to disclose the purchase price.

The Greenberg Traurig team provided comprehensive advice to Gilde Healthcare on all legal aspects of the transaction. In addition to the share purchase agreement, the advice included a shareholders' agreement for the future partnership.

Background: Gilde Healthcare regularly works with Greenberg Traurig on buyouts, most recently in the acquisition of the medical technology manufacturers EUROPIN this year and Acti-Med in 2021. The instruction on the now completed acquisition underscores the strength of the firm in private equity transactions in the healthcare sector.

About Greenberg TraurigGreenberg Traurig, LLP has more than 2400 attorneys in 42 locations in the United States, Europe, Latin America, Asia, and the Middle East. The firm, often recognized for its focus on philanthropic giving, innovation, diversity, and pro bono, reported gross revenue of over $2 Billion for FY 2021. The firm is consistently among the top firms on the Am Law 100, Am Law Global 100, NLJ 250, and Law360 (US) 400. On the debut 2022 Law360 Pulse Leaderboard, it is a Top 15 firm. Greenberg Traurig is Mansfield Rule 4.0 Certified Plus by The Diversity Lab and net carbon neutral with respect to its office energy usage. Web: www.gtlaw.com.